Chemical Compound

[(7S,9E,11S,12R,13S,14R,16R,17S,18S,19E,21Z)-2,15,17,36-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate

CAS Registry Number 80621-81-4
返回搜索 申请报价
[(7S,9E,11S,12R,13S,14R,16R,17S,18S,19E,21Z)-2,15,17,36-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate 结构式
Primary record

[(7S,9E,11S,12R,13S,14R,16R,17S,18S,19E,21Z)-2,15,17,36-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate

库存
5,109 克
纯度
99.5 %
CAS
80621-81-4

化合物标识与属性

CAS
80621-81-4
PubChem CID
16667733
SMILES
C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H](C([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C
Canonical SMILES
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)C(O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C

名称与同义词

  • Rifaximin
  • Fatroximin
  • Rifaximina
  • Rifaximine
  • Rifaximinum
  • Rifamixin
  • Rifaxidin
  • Rifacol
  • Rifaxin
  • Ritacol
  • Xifaxan
  • Normix
  • Rifamycin L 105
  • Rifaximine [French]
  • Rifaximinum [Latin]
  • Rifaximina [Spanish]
  • Rifamycin L 105SV
  • Rifaximin [USAN:INN]
  • BSPBio_003545
  • Rifaximin [USAN:INN:BAN]
  • SPECTRUM1505321
  • UNII-L36O5T016N
  • SCHEMBL16229249
  • L 105SV
  • HMS2093B17
  • Pharmakon1600-01505321
  • L 105 (Ansamacrolide antibiotic)
  • C43H51N3O11
  • CCG-39867
  • NSC758957
  • C43-H51-N3-O11
  • NSC-758957
  • BRN 3584528
  • L 105
  • AB01563059_01
  • SR-05000001803
  • SR-05000001803-1
  • 80621-81-4
  • 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV
  • [(7S,9E,11S,12R,13S,14R,16R,17S,18S,19E,21Z)-2,15,17,36-Tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate
  • 4-deoxy-4'-methylpyrido[1',2'-1,2]-nu-imidazo[5,4-c]rifamycin SV
  • (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate
  • 2,7-(Epoxypentadeca[1,11,13]trienimino)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-